Company news

Agios Pharmaceuticals, Inc. news in 2023

Agios Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition

December 8, 2023

Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes

November 19, 2023

Agios Reports Business Highlights and Third Quarter 2023 Financial Results

November 1, 2023

Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Rare Blood Disorders at 65th ASH Annual Meeting and Exposition

November 1, 2023

Agios to Webcast Conference Call of Third Quarter 2023 Financial Results on Nov. 2, 2023

October 18, 2023

Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023

August 28, 2023

Agios Reports Business Highlights and Second Quarter 2023 Financial Results

August 2, 2023

Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera

August 2, 2023

Agios to Webcast Conference Call of Second Quarter 2023 Financial Results on Aug. 3, 2023

July 12, 2023

Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response

June 25, 2023

Agios to Present at the Goldman Sachs Global Healthcare Conference on June 15, 2023

June 4, 2023

Agios Appoints Catherine Owen to Board of Directors

May 24, 2023

Agios to Present Clinical and Translational Data at European Hematology Association Annual Congress

May 10, 2023

Agios Reports Business Highlights and First Quarter 2023 Financial Results

May 3, 2023

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 16, 2023

April 24, 2023

Agios Appoints Jeffrey Capello to Board of Directors

April 18, 2023

Agios to Webcast Conference Call of First Quarter 2023 Financial Results on May 4, 2023

April 12, 2023

Agios Publishes 2023 Environmental, Social and Governance (ESG) Report

April 2, 2023

Agios to Participate in March Investor Conferences

March 1, 2023

Agios Launches “Red Cell Revolution” in Recognition of Rare Disease Day

February 27, 2023

Agios Reports Fourth Quarter and Full Year 2022 Financial Results

February 22, 2023

Agios to Webcast Conference Call of Fourth Quarter and Year End 2022 Financial Results on Feb. 23, 2023

February 1, 2023

Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company’s Vision to Transform Patient Outcomes in Rare Diseases

January 7, 2023

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

January 2, 2023

Calls in 2023

Decks in 2023